Disease | CD14 ++CD16 -(Classical, phagocytic) | CD14 ++CD16 +(Intermediate, inflammatory) | CD14 +CD16 ++(Non-classical, patrolling) | Functional change associated with CD14 ++CD16 -MC expansion | PMID # |
---|---|---|---|---|---|
Congestive HF |  | 6.4%↑ |  | CD143 (ACE) ↑, Creatine↑, GFR↓, albumin↓ | 20364047 |
CKD |  | 42 → 70 cells/μl | 55 → 130 cells/μl |  | 20943670 |
RA |  | 5%↑ |  | Th17 cells expansion | 22006178 |
AAA |  | 2.24%↑ | 1.9%↑ |  | 23348634 |
Stroke |  | 3%↑ | 3%↓ |  | 19293821 |
HIV-2 |  | 7%↑ |  | Myeloid dendritic cell depletion | 23460749 |
Sepsis | No change | 11.5%↑ | 6%↑ | Phagocytosis↓, CD86↑, HLA-DR↓, IL-1β↓, IL-10↑ | 12028567 |
Sepsis | 9.5%↓ | 12%↑ | 3.4%↓ | HLA-DR↓, TNFα & IL-1β ↓,IL-10↑ | 19604380 |
Hepatitis B | 6.2%↓ | 3.3%↑ | 2.5%↑ | HLA-DR↑,TNF α ↑, IL-6↑, IL1β ↑, Th17 cells expansion | 21390263 |
HIV | 2.5%↓ | 3%↑ | 3%↑ | CD163(scavenger receptor)↑ | 21625498 |
Denque fever | 12 ~ 18%↓ | 3 ~ 7%↑ |  | HLA-DR ↓, ICAM ↑, serum TNFα↑, IL-18 ↑, IFNγ ↑ , | 20113369 |
Tuberculosis | 10%↓ | 9%↑ | 13%↑ | TNFα ↑, apoptosis↑, Il-10↓ | 21621464 |